KEQU · Kewaunee Scientific Corp
Market Cap
$93.75M
Shares
2.90M
Volume · Oct 23
1778
Avg daily vol (3M)
3526
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$32.79
Open$32.20
Day$32.20–32.79
52W close$32.10–45.36
Avg vol 30d4K
Short int44K · 1.5% float · 8.0d
Short vol27%
DataJan 2020–Oct 2026
Filing10-Q · Sep 11
Up next
filed Sep 11, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$277.21M
Trailing 12 months
Net income (TTM)
$8.23M
Trailing 12 months
Revenue growth YoY
-6.7%
Year over year
Operating margin
5.4%
Trailing 12 months
P / E (TTM)
11.7
Trailing earnings · reciprocal yield 8.5%
FCF yield
11.6%
TTM · current market cap
Return on invested capital
13.0%
Trailing 12 months
Net cash
−$10.59M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-1.4%
Year over year · fewer shares
Price change (1Y)
-29.7%
Trailing year
Short interest
1.5%
Latest settlement · 8.0 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Moderate
Market backdrop
VIX 19 · elevated
Equity put/call 0.69
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−11%
below
Price vs 50-day avg
−6%
below
RSI (14)
44
neutral
MACD trend
Positive
52-week position
5%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−4%
trailing
6-month return
−13%
trailing
YTD return
−12%
this year
Relative strength
−19%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $35 › 200d $37 — 200d above 50d
Institutional flow
Accumulating
3 of 32 funds reported for Sep 30 · net +148 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.52% of float · ▼ -10.1% MoM · 8.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
32 holders — mid 3-yr range
Squeeze score
45
elevated · 0–100
Fundamentals
Revenue growth
+8%
Y/Y
Gross margin
58%
expanding
EPS growth
−16%
Y/Y
Valuation
P/E 11.7
in line
Balance sheet
$10.1M
net debt
Quant / Vol
risk profile
Volatility
34%
annualized · 1-yr
Max drawdown
−30%
past year
ATR
2.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−11%
Bearish
Price vs 50-day avg
−6%
Bearish
RSI (14)
44
Neutral
MACD trend
Positive
Bullish
52-week position
5%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $35 › 200d $37 — 200d above 50d
Institutional flow
Accumulating
3 of 32 funds reported for Sep 30 · net +148 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.52% of float · ▼ -10.1% MoM · 8.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
32 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $32
Now $33 · 5%
Range high $45
vs 200-day avg -11%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Effective income tax rate | 28% | the three months ended July 31, 2026 filing | — |
| Gross profit margin | 29.6% | the three months ended July 31, 2026 filing | — |
| Operating expenses as a percent of sales | 24.9% | the three months ended July 31, 2026 filing | — |
| Backlog | $169M | July 31, 2026 | — |
| Capital expenditures | $3,937,000 | fiscal year 2026 filing | — |
| International order backlog | $47.1M | fiscal year 2026 filing | — |
| LPG order backlog | $118.8M | fiscal year 2026 filing | — |
| Net cash provided by operating activities | $18,633,000 | fiscal year 2026 filing | — |
| Net cash used by financing activities | $19,326,000 | fiscal year 2026 filing | — |
| Net sales derived in currencies other than U.S. dollars | 22% | fiscal year 2026 filing | — |
| Order backlog | $165.9M | fiscal year 2026 filing | — |
| Research and experimentation expenditures | $898,000 | fiscal year ended April 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Furnishings, Fixtures & Appliances — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KEQU
this stock
Kewaunee Scientific Corp
|
$93.75M | -12.3% | +7.7% | 11.7 | 1.5% |
|
MGCLY
Midea Group Co., Ltd.
|
$90.57B | +10.0% | — | — | 0.0% |
|
SN
SharkNinja, Inc.
|
$28.06B | +75.5% | +15.7% | — | 6.3% |
|
SGI
Somnigroup International Inc.
|
$13.88B | -27.6% | -12.0% | — | 8.9% |
|
NCLTY
Nitori Holdings Co., Ltd.
|
$11.96B | +20.3% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KEQU | -0.4% | -3.6% | -13.1% | -4.8% | -12.4% |
| SPY | -0.4% | -1.5% | +5.8% | -0.4% | +11.5% |
| vs SPY | +0.0% | -2.1% | -18.9% | -4.5% | -23.8% |
Capital returns
Buyback program
· as of Jul 31, 2026
Authorized
shares 100,000
Spent (derived)
shares 13,687
Remaining
shares 86,313
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.